Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Clin Lung Cancer. 2013 Jul 1;14(5):581–591. doi: 10.1016/j.cllc.2013.05.002

Table 3.

Associations between Patient Characteristics and EGFR and KRAS Mutations

EGFR Mutation Status
Variable Positive Negative t test P value
# Mean ± SE # Mean ± SE
Age 60 65.1 ± 1.4 303 62.9 ± 0.7 0.18
Charlson Comorbidity Index 60 5.1 ± 0.3 303 5.9 ± 0.1 0.002
Age-weighted Comorbidity Index 60 7.1 ± 0.3 303 7.9 ± 0.1 0.02
KRAS Mutation Status
Variable Mutant Wild Type t test P value
# Mean ± SE # Mean ± SE
Age 83 62.3 ± 1.1 207 62.6 ± 0.9 0.82
Charlson Comorbidity Index 83 6.0 ± 0.2 206 5.8 ± 0.1 0.31
Age-weighted Comorbidity Index 83 7.9 ± 0.2 206 7.7 ± 0.2 0.46